The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
Official Title: Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
Study ID: NCT03727087
Brief Summary: The primary objective of this study is to obtain de-identified, clinically characterized, whole blood specimens to evaluate biomarkers associated with cancer for diagnostic assay development.
Detailed Description: Subjects will have been recently diagnosed with untreated melanoma. Subjects will have a blood sample collected at enrollment and provide medical history prior to initiation of treatment. There will be no further follow-up.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
CARTI Cancer Center, Little Rock, Arkansas, United States
Alliance Research Centers, Laguna Hills, California, United States
Palmtree Clinical Research, Inc, Palm Springs, California, United States
San Fernando Valley Health Institute, Van Nuys, California, United States
Middlesex Hospital, Middletown, Connecticut, United States
The Stamford Hospital, Stamford, Connecticut, United States
Direct Helpers Research Center, Hialeah, Florida, United States
East Coast Institute for Research, LLC, Jacksonville, Florida, United States
Mid-Florida Hematology and Oncology Center, Orange City, Florida, United States
Olympian Clinical Research, Tampa, Florida, United States
Balanced Life Health Care Solutions, LLC, Buford, Georgia, United States
IACT Health (DBA John B. Amos Cancer Center), Columbus, Georgia, United States
PMG Research, INC, Downers Grove, Illinois, United States
Carle Cancer Center NCI, Urbana, Illinois, United States
Franciscan Health Indianapolis, Indianapolis, Indiana, United States
St. Elizabeth Medical Center, Edgewood, Kentucky, United States
DermAssociates, PC, Rockville, Maryland, United States
Cancer Research Consortium of West Michigan, Grand Rapids, Michigan, United States
HealthPartner Institute, Bloomington, Minnesota, United States
MediSync Clinical Research, Petal, Mississippi, United States
Somnos Laboratories, Inc., Lincoln, Nebraska, United States
Cancer Alliance of Nebraska, Omaha, Nebraska, United States
East Carolina University Brody School of Medicine, Greenville, North Carolina, United States
PMG Research of Rocky Mount, LLC, Rocky Mount, North Carolina, United States
MediSync Clinical Research, Dayton, Ohio, United States
Spartanburg Regional Healthcare District, Spartanburg, South Carolina, United States
Lexington Medical Center, West Columbia, South Carolina, United States
The Jackson Clinic Professional Association, Jackson, Tennessee, United States
MediSync Clinical Research, Austin, Texas, United States
Austin Institute for Clinical Research, Pflugerville, Texas, United States
MediSync Clinical Research, Pflugerville, Texas, United States
Aim Trials, LLC, Plano, Texas, United States
Wenatchee Valley Hospital, Wenatchee, Washington, United States
Dean Clinic - Fort Atkinson Specialty Services, Fort Atkinson, Wisconsin, United States
HSHS St Vincent Hospital Regional Cancer Center, Green Bay, Wisconsin, United States
ProHealth Care, Oconomowoc, Wisconsin, United States